Skip to main content
Premium Trial:

Request an Annual Quote

RainDance Joins French HTS Screening Consortium

NEW YORK (GenomeWeb News) – Microfluidics company RainDance Technologies said today that it has joined a French consortium to develop a microfluidic system for use in quantitative high-throughput screening of potential drug compounds.
 
In addition to the Lexington-Mass.-based company, the dScreen Consortium includes the drug-maker Sanofi-Aventis and the Institute for Science and Supramolecular Engineering at Louis Pasteur University of Strasbourg. The consortium was founded with assistance from the Alsace BioValley cluster.
 
One of the consortium’s goals is to develop a microfluidic system for quantitative high-throughput screening of bio-active compounds using purified targets and cell-based assays. Such a system would enable researchers to gauge dose-response curves for compounds in a chemical library.
 
Another effort will be to develop a new system for storing compounds in which each compound will be stored in droplets using a microfluidic device.
 
"The simplicity, speed and minute volume of our technology replace current complex automation solutions in high-throughput screening,” RainDance Technologies CEO Chris McNary said in a statement. “Our technology will process 10 million droplets per hour on a single benchtop instrument, dramatically accelerating the drug discovery process while conserving precious screening compounds."
 

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.